542
Views
7
CrossRef citations to date
0
Altmetric
Editorial

Pancreatic cancer: current standards, working towards a new therapeutic approach

&

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Guopei Luo, Yu Lu, Kaizhou Jin, He Cheng, Meng Guo, Zuqiang Liu, Jiang Long, Chen Liu, Quanxing Ni & Xianjun Yu. (2015) Pancreatic cancer: BRCA mutation and personalized treatment. Expert Review of Anticancer Therapy 15:10, pages 1223-1231.
Read now

Articles from other publishers (6)

Ahmet Kaynak, Harold W. Davis, Andrei B. Kogan, Jing-Huei Lee, Daria A. Narmoneva & Xiaoyang Qi. (2022) Phosphatidylserine: The Unique Dual-Role Biomarker for Cancer Imaging and Therapy. Cancers 14:10, pages 2536.
Crossref
Kun Fan, Zhiyao Fan, He Cheng, Qiuyi Huang, Chao Yang, Kaizhou Jin, Guopei Luo, Xianjun Yu & Chen Liu. (2019) Hexokinase 2 dimerization and interaction with voltage‐dependent anion channel promoted resistance to cell apoptosis induced by gemcitabine in pancreatic cancer. Cancer Medicine 8:13, pages 5903-5915.
Crossref
Vaishali Bagalkot, Jeffrey A. Deiuliis, Sanjay Rajagopalan & Andrei Maiseyeu. (2016) “Eat me” imaging and therapy. Advanced Drug Delivery Reviews 99, pages 2-11.
Crossref
Mahaboob K Sulaiman, Zhengtao Chu, Victor M Blanco, Subrahmanya D Vallabhapurapu, Robert S Franco & Xiaoyang Qi. (2015) SapC-DOPS nanovesicles induce Smac- and Bax-dependent apoptosis through mitochondrial activation in neuroblastomas. Molecular Cancer 14:1.
Crossref
YU WANG, CAIJUN YUAN & XIAOMEI LIU. (2015) Characteristics of gastrointestinal hemorrhage associated with pancreatic cancer: A retrospective review of 246 cases. Molecular and Clinical Oncology 3:4, pages 902-908.
Crossref
Victor M. Blanco, Tahir Latif, Zhengtao Chu & Xiaoyang Qi. (2015) Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles. Translational Oncology 8:3, pages 196-203.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.